Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02073292 · ClinicalTrials.gov registry record · NA

Cooled Radiofrequency Ablation vs. Thermal Radiofrequency Ablation

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT02073292: Completed NA study, sponsored by The Cleveland Clinic.

NCT02073292 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02073292, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

Nerves in your body transmit signals to and from your brain and the cells in your body. In the event of an injury or disease, these nerves transmit pain. Sometimes, when an injury doesn't heal, chronic pain can develop. One way to treat chronic pain is to interrupt these pain signals. One method of doing this is to use Radio frequency ablation (RFA). Radio frequency ablation (RFA) is a medical procedure in which heat is generated from high frequency electrical current in order to lesion (burn) nervous tissue. Radiofrequency ablation is used to treat many conditions in several areas of the body including cardiac (heart) as well as chronic pain. Probes (needles) are inserted into the body to a specific location and the electrical current is passed through these needles. This electrical current creates heat in your body and forms small lesions or burns in a specific place. Doctors will use tools, such as fluoroscopy (x-rays) and injections to locate the specific nerves that are transmitting pain and then use the electrical current to destroy those nerves. Equipment used include generator, built in nerve stimulator, different needles and probes and water cooling system in case of the cooled RFA. There are several types of probes or needles that are used to transmit energy and create lesions. This study is going to compare 2 types - standard radiofrequency and 'cooled' radiofrequency. The only difference is that the 'cooled' radiofrequency probes have water running through the probe tip, which keeps the tip cool and allows a larger lesion to be made. Since the doctor can't actually see the nerve he is trying to target, the larger lesion should theoretically improve his chances of hitting it. The 'cooling' of the water also allows the temperatures to be lower than what is needed for standard RF. In this study, the investigators would like to compare the differences between standard RFA (90°C) and "cooled" RFA (60°C) ablation techniques and determine if one is better fo

Interventions

  • PROCEDURE c-RFA
  • PROCEDURE tRFA

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2014-03
Est. Completion 2022-12-15
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT02073292 record still lists

NCT02073292 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which c-RFA is the first listed.

NCT02073292 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02073292 about?

NCT02073292 is a clinical study titled "Cooled Radiofrequency Ablation vs. Thermal Radiofrequency Ablation". Nerves in your body transmit signals to and from your brain and the cells in your body. In the event of an injury or disease, these nerves transmit pain. Sometimes, when an injury doesn't heal, chronic pain can develop. One way to treat chronic pain is to interrupt these pain signals. One method of ...

What is the current status of trial NCT02073292?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2014-03. Estimated completion is 2022-12-15.

What interventions are being tested in trial NCT02073292?

The interventions under investigation include: c-RFA (PROCEDURE), tRFA (PROCEDURE).

Who is sponsoring clinical trial NCT02073292?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02073292's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02073292, the US trial registry maintained by the National Library of Medicine. NCT02073292 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.